Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-12.28%
Price
13.03.26
€202.10
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -12.28%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -7.251% | -7.251% |
| iShares Core DAX® | -1,10 % | -6,08 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % |
| iShares S&P 500 | -0,06 % | 0,88 % |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat